B
Beth Abood
Researcher at Cleveland Clinic
Publications - 8
Citations - 2825
Beth Abood is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Type 2 diabetes & Weight loss. The author has an hindex of 8, co-authored 8 publications receiving 2625 citations.
Papers
More filters
Journal ArticleDOI
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Philip R. Schauer,Sangeeta R. Kashyap,Kathy Wolski,Stacy A. Brethauer,John P. Kirwan,Claire E. Pothier,Susan Thomas,Beth Abood,Steven E. Nissen,Deepak L. Bhatt,Deepak L. Bhatt +10 more
TL;DR: In obese patients with uncontrolled type 2 diabetes, 12 months of medical therapy plus bariatric surgery achieved glycemic control in significantly more patients than medical therapy alone.
Journal ArticleDOI
Bariatric Surgery Versus Intensive Medical Therapy in Obese Patients With Diabetes
Philip R. Schauer,Sangeeta R. Kashyap,Kathy Wolski,Stacy A. Brethauer,John P. Kirwan,Claire E. Pothier,Susan Thomas,Beth Abood,Steven E. Nissen,Deepak L. Bhatt +9 more
TL;DR: In this paper, the authors showed that the use of drugs to lower glucose, lipid, and blood-pressure levels decreased significantly after both surgical procedures but increased in patients receiving medical therapy only.
Journal ArticleDOI
Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment
Sangeeta R. Kashyap,Deepak L. Bhatt,Kathy Wolski,Richard M. Watanabe,Muhammad A. Abdul-Ghani,Beth Abood,Claire E. Pothier,Stacy A. Brethauer,Steven E. Nissen,Manjula K. Gupta,John P. Kirwan,Philip R. Schauer +11 more
TL;DR: Despite similar weight loss as sleeve gastrectomy, gastric bypass uniquely restores pancreatic β-cell function and reduces truncal fat, thus reversing the core defects in diabetes.
Journal ArticleDOI
Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy.
Adam H. Maghrabi,Kathy Wolski,Beth Abood,Angelo A. Licata,Claire E. Pothier,Deepak L. Bhatt,Deepak L. Bhatt,Steven E. Nissen,Stacy A. Brethauer,John P. Kirwan,Philip R. Schauer,Sangeeta R. Kashyap +11 more
TL;DR: To determine the 2‐year outcomes of Roux‐en‐Y gastric bypass (RYGB) and sleeve gastrectomy (SG) vs. intensive medical therapy (IMT) on lean body mass, total bone mass, and bone mineral density (BMD) measures from the STAMPEDE trial, data are analyzed.
Journal ArticleDOI
Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy
Steven K. Malin,A. Samat,Katherine E. Wolski,Beth Abood,Claire E. Pothier,Deepak L. Bhatt,Steven E. Nissen,Stacy A. Brethauer,Philip R. Schauer,John P. Kirwan,Sangeeta R. Kashyap +10 more
TL;DR: Enhanced AG suppression persists for up to 2 years after RYGB, and this effect is associated with decreased android obesity and improved insulin secretion, which suggest that AG suppression is partly responsible for the improved glucose control after RyGB surgery.